Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The injectable antiretroviral could potentially be taken once every six months for HIV treatment or PrEP.
The long-acting regimen will enable some adolescents to take their HIV treatment just six times a year.
People can now start Cabenuva injections directly without first taking cabotegravir and rilpivirine pills for a month.
The every-other-month schedule of injectable cabotegravir plus rilpivirine enables some people to take HIV treatment just six times a year.
The injectable antiretroviral could potentially be given once every six months for HIV treatment or prevention.
Using the new dosing schedule, injectable cabotegravir and rilpivirine can be administered just six times a year.
Long-acting injectable Cabenuva works well in people with obesity.
Every-other-month cabotegravir injections may work even better than daily pills for HIV prevention.
The long-acting injectable regimen suppressed HIV in more than 90% of study participants, including those with obesity.
This issue explores the latest choices in HIV regimens for various groups, including youth and older people.
Here are considerations for long-term survivors thinking about switching HIV treatments.
Under 30? Here’s what to consider if you’re thinking about switching HIV treatments.
Switching to a long-acting injectable was right on time for these three people living with HIV.
Lenacapavir, a twice-yearly injectable, suppresses viral load in people with highly resistant virus.
Long-acting injections given every two months could soon offer a new option for HIV pre-exposure prophylaxis.
Injections of cabotegravir given once every two months may work even better than daily pills for HIV prevention.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.